What is Lucid Diagnostics's shares (basic)?

Lucid Diagnostics (LUCD) reported shares (basic) of 140.1M in Q1 2026.

How has Lucid Diagnostics's shares (basic) changed year-over-year?

Lucid Diagnostics's shares (basic) increased by 103.6% year-over-year, from 68.8M to 140.1M.

What is the long-term trend for Lucid Diagnostics's shares (basic)?

Over 4 years (2021 to 2025), Lucid Diagnostics's shares (basic) has grown at a 57.8% compound annual growth rate (CAGR), from 60.9M to 377.9M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Lucid Diagnostics LUCD Shares (Basic)

Shares (Basic) at other companies

Castle BiosciencesCSTL

29.9M+4.5%

Guardant HealthGH

131.3M+6.0%

Biodesix, Inc.BDSX

9.7M+32.3%

Insight Molecular Diagnostics Inc. Common StockIMDX

34.5M+34.3%

Fulgent Genetics, Inc.FLGT

30.9M+0.2%

Personalis, Inc.PSNL

104.2M+19.1%

Other financials

Income statement

See full

Revenue$1.3M+51.7%

Gross profit-$369.0K+49.0%

Operating income-$12.1M+3.0%

Net income-$13.9M+48.3%

EPS (diluted)-$0.10+60.0%

Balance sheet

See full

Cash & equivalents$27.9M+10.6%

Total debt$1.6M-35.1%

Total equity$4.0M+174%

Total assets$34.1M+3.9%

Cash flow

See full

Operating cash flow-$12.1M+2.9%

CapEx$215.0K+131%

Free cash flow-$12.3M+1.9%

Valuation

See full

Market cap$204.13M+58.5%

Enterprise value$177.85M+78.0%

P/S39.8×+10.2×

Profitability

See full

Gross margin-66.8%—

Operating margin-959.6%-133pp

Net margin-876.7%-254pp

FCF margin-1,099.6%—

Returns & leverage

See full

Return on equity-710.6%—

Debt / equity0.4×—

Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lucid Diagnostics's shares (basic)?: Lucid Diagnostics (LUCD) reported shares (basic) of 140.1M in Q1 2026.
How has Lucid Diagnostics's shares (basic) changed year-over-year?: Lucid Diagnostics's shares (basic) increased by 103.6% year-over-year, from 68.8M to 140.1M.
What is the long-term trend for Lucid Diagnostics's shares (basic)?: Over 4 years (2021 to 2025), Lucid Diagnostics's shares (basic) has grown at a 57.8% compound annual growth rate (CAGR), from 60.9M to 377.9M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.